MARKET

GWPH

GWPH

GW Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

100.18
-1.83
-1.79%
After Hours: 99.71 -0.47 -0.47% 18:03 09/18 EDT
OPEN
101.90
PREV CLOSE
102.01
HIGH
102.16
LOW
98.65
VOLUME
659.02K
TURNOVER
--
52 WEEK HIGH
141.98
52 WEEK LOW
67.98
MARKET CAP
3.12B
P/E (TTM)
-56.1044
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average GWPH stock price target is 190.69 with a high estimate of 275.00 and a low estimate of 136.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About GWPH
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of GW Pharmaceuticals PLC- ADR stock information, including NASDAQ:GWPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GWPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GWPH stock methods without spending real money on the virtual paper trading platform.